browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
12e75bdc-39a5-417e-8549-cb7b712f69ae
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:55:24
Income (reported)
—
Expenses (reported)
$700,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

SIEMENS MEDICAL SOLUTIONS USA, INC

Healthcare diagnostics

Contact
CATHERINE NABAVI
Phone
+1 484-323-1671
Address
zip:20004, city:Washington, state:DC, street:801 Pennsylvania Avenue, NW Suite 520
Client

SIEMENS MEDICAL SOLUTIONS USA, INC

State
DC
Country
US
Government-entity client
false
Effective date
2021-01-01
Issues lobbied + lobbyists (5)

HCR — Health Issues

Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to data privacy standards and transparency; and Issues related to right to repair for medical devices.

Lobbyists:
  • AARON HUNTER
  • ms ELIZABETH RAYE KEGLER
  • mrs CATHERINE HANSEN NABAVI

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.

Lobbyists:
  • mrs CATHERINE HANSEN NABAVI
  • AARON HUNTER
  • ms ELIZABETH RAYE KEGLER

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TRD — Trade (domestic/foreign)

Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review; Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.

Lobbyists:
  • mrs CATHERINE HANSEN NABAVI
  • AARON HUNTER
  • ms ELIZABETH RAYE KEGLER
  • ms SARAH ELIZABETH GIANNI

Government entities lobbied: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE

TAR — Tariff (miscellaneous tariff bills)

Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.

Lobbyists:
  • mrs CATHERINE HANSEN NABAVI
  • AARON HUNTER
  • ms ELIZABETH RAYE KEGLER

Government entities lobbied: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE

BUD — Budget/Appropriations

H.R. 5304 / S. S587 / H. Rept. 119-271 / S. Rept. 117-55 - Labor-HHS-Education Appropriation Act, FY 2026;

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.